Our immune system’s relationship with cancer is very complex. Certain types of immune cells called regulatory T-cells, while vital for a balanced immune system, can hinder the cancer-killing process. Targeting these cells without affecting other immune cells in the past has been difficult. Cancer Research UK scientists from University College London in collaboration with Roche have developed a new drug that can stop regulatory T-cells from working while leaving other immune cells intact to fight the cancer cells. Watch this drug in action in this short animation.
Read more about the link between the immune system and cancer on our Science blog: [ Ссылка ]
#immunotherapy
Subscribe: youtube.com/user/cancerresearchuk
Facebook: facebook.com/cancerresearchuk
Twitter: twitter.com/CR_UK
Instagram: instagram.com/cr_uk
